Amanote Research

Amanote Research

    RegisterSign In

The Prognostic Value of Flipi in the Era of Rituximab

Hematological Oncology - United Kingdom
doi 10.1002/hon.2439_125
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineCancer ResearchOncologyHematology
Date

June 1, 2017

Authors
T. Juznic SetinaS. BorstnarB. Jezersek Novakovic
Publisher

Wiley


Related search

A New Prognostic Score for AIDS-related Lymphomas in the Rituximab-Era

Haematologica
Hematology
2014English

M7‐FLIPI Is Not Prognostic in Follicular Lymphoma Patients With First‐line Rituximab Chemo‐free Therapy

British Journal of Haematology
Hematology
2019English

The Kyoto Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma in the Rituximab Era

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

The Era of High-Value Care

AMA journal of ethics
Health PolicyEthicsHealthIssuesLegal Aspects
2015English

Prognostic Value of T-Wave Morphology Parameters in Coronary Artery Disease in Current Treatment Era

Annals of Noninvasive Electrocardiology
MedicineCardiovascular MedicinePhysiologyCardiology
2018English

The Prognostic Value of Troponin in Pediatric Polytrauma

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2019English

The Prognostic Value of Lactate Acid in Sepsis

Health & Research Journal
2018English

Individualized Prognostic Calculators in the Precision Oncology Era

Oncotarget
Oncology
2019English

The Value of Population-Based Studies in the Genomic Era

Ophthalmic Epidemiology
EpidemiologyOphthalmology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy